High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma

BACKGROUND: High-dose chemotherapy with autologous stem cell transplantation is a cornerstone in the first-line treatment of multiple myeloma patients. However, only few factors have been identified affecting the outcome in such patients. We hypothesised that varying levels of mobilised CD34+ cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Raschle, J, Ratschiller, D, Mans, S, Mueller, B U, Pabst, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185945/
https://www.ncbi.nlm.nih.gov/pubmed/21878938
http://dx.doi.org/10.1038/bjc.2011.329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185945/
https://www.ncbi.nlm.nih.gov/pubmed/21878938
http://dx.doi.org/10.1038/bjc.2011.329

Ejemplares similares